HC Wainwright & Co. Reiterates Buy on Adicet Bio, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Adicet Bio (NASDAQ:ACET) and maintained a price target of $10.
June 05, 2024 | 3:23 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Adicet Bio and maintained a price target of $10, indicating confidence in the company's future performance.
The reiteration of a Buy rating and maintenance of a $10 price target by a reputable analyst firm like HC Wainwright & Co. is likely to boost investor confidence in Adicet Bio, potentially leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100